Nancy Amoroso is a Respiratory physician affiliated with New York University. OpenAlex indexes 48 publications with 1,832 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
- Abbott LaboratoriesProgram year20221 payment
- CSL BehringProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Factor Xa inhibitor100%Eliquis59%Xarelto41%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Time to Catheter-Based Therapy on Outcomes in Acute Pulmonary Embolism
Circulation Cardiovascular Interventions
2025 - Anticoagulation alone versus large-bore mechanical thrombectomy in acute intermediate-risk pulmonary embolism
Cardiovascular revascularization medicine
2025 - Successful Autologous Hematopoietic Stem Cell Transplant While on Venovenous Extracorporeal Membrane Oxygenation Support
American Journal of Respiratory and Critical Care Medicine
2025 - IMPACT OF TIME TO CATHETER-BASED THERAPY ON OUTCOMES IN ACUTE PULMONARY EMBOLISM
Journal of the American College of Cardiology
2025 - Searching for the PE Sorting Hat: Comparing PE Biomarkers and Response to Therapy
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Alper, MD
New York University
William Rom, MD
New York University
Alec Megibow, MD
New York University
Jerry Shapiro, MD
New York University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”